Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: MULTIPLE SCLEROSIS - EPIDEMIOLOGY , . Treffer: 13
2019
Walleczek, NK; Frommlet, F; Bsteh, G; Eggers, C; Rauschka, H; Koppi, S; Assar, H; Ehling, R; Birkl, C; Salhofer-Polanyi, S; Baumgartner, A; Blechinger, S; Buchinger, D; Sellner, J; Kraus, J; Moser, H; Mayr, M; Guger, M; Rathmaier, S; Raber, B; Liendl, H; Hiller, MS; Parigger, S; Morgenstern, G; Kempf, I; Spiss, HK; Meister, B; Heine, M; Cisar, A; Bachler, H; Khalil, M; Fuchs, S; Enzinger, C; Fazekas, F; Leutmezer, F; Berger, T; Kristoferitsch, W; Aboulenein-Djamshidian, F
Month-of-birth-effect in multiple sclerosis in Austria.
Mult Scler. 2019; 25(14):1870-1877
Doi: 10.1177/1352458518810924
Web of Science
PubMed
FullText
FullText_MUG
2015
Rocca, MA; Amato, MP; De Stefano, N; Enzinger, C; Geurts, JJ; Penner, IK; Rovira, A; Sumowski, JF; Valsasina, P; Filippi, M; MAGNIMS Study Group
Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis.
Lancet Neurol. 2015; 14(3):302-317
Doi: 10.1016/S1474-4422(14)70250-9
Web of Science
PubMed
FullText
FullText_MUG
2014
Bechtold, S; Blaschek, A; Raile, K; Dost, A; Freiberg, C; Askenas, M; Fröhlich-Reiterer, E; Molz, E; Holl, RW
Higher relative risk for multiple sclerosis in a pediatric and adolescent diabetic population: analysis from DPV database.
Diabetes Care. 2014; 37(1):96-101
Doi: 10.2337/dc13-1414
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kapfhammer, HP
[Coexistent depressive and anxiety disorders in epilepsy and multiple sclerosis: a challenge to neuropsychiatric practice].
Neuropsychiatr. 2014; 28(3):142-150
Doi: 10.1007/s40211-014-0105-y
PubMed
FullText
FullText_MUG
Miller, DH; Fazekas, F; Montalban, X; Reingold, SC; Trojano, M
Pregnancy, sex and hormonal factors in multiple sclerosis.
MULT SCLER J. 2014; 20(5): 527-536.
Doi: 10.1177/1352458513519840
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Robier, C; Amouzadeh-Ghadikolai, O; Bregant, C; Diez, J; Melinz, K; Neubauer, M; Quasthoff, S
The anti-VLA-4 antibody natalizumab induces erythroblastaemia in the majority of the treated patients with multiple sclerosis.
Mult Scler. 2014; 20(9):1269-1272
Doi: 10.1177/1352458514521307
Web of Science
PubMed
FullText
FullText_MUG
2012
Baracchini, C; Valdueza, JM; Del Sette, M; Baltgaile, G; Bartels, E; Bornstein, NM; Klingelhoefer, J; Molina, C; Niederkorn, K; Siebler, M; Sturzenegger, M; Ringelstein, BE; Russell, D; Csiba, L
CCSVI and MS: a statement from the European Society of neurosonology and cerebral hemodynamics.
J NEUROL. 2012; 259(12): 2585-2589.
Doi: 10.1007/s00415-012-6541-3
Web of Science
PubMed
FullText
FullText_MUG
2006
Burwick, RM; Ramsay, PP; Haines, JL; Hauser, SL; Oksenberg, JR; Pericak-Vance, MA; Schmidt, S; Compston, A; Sawcer, S; Cittadella, R; Savettieri, G; Quattrone, A; Polman, CH; Uitdehaag, BM; Zwemmer, JN; Hawkins, CP; Ollier, WE; Weatherby, S; Enzinger, C; Fazekas, F; Schmidt, H; Schmidt, R; Hillert, J; Masterman, T; Hogh, P; Niino, M; Kikuchi, S; Maciel, P; Santos, M; Rio, ME; Kwiecinski, H; Zakrzewska-Pniewska, B; Evangelou, N; Palace, J; Barcellos, LF
APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.
NEUROLOGY. 2006; 66(9): 1373-1383.
Doi: 10.1212/01.wnl.0000210531.19498.3f
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Fazekas, F; Enzinger, C; Ropele, S; Schmidt, H; Schmidt, R; Strasser-Fuchs, S
The impact of our genes: consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis.
J NEUROL SCI. 2006; 245(1-2): 35-39.
Doi: 10.1016/j.jns.2005.08.018
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Li, DK; Held, U; Petkau, J; Daumer, M; Barkhof, F; Fazekas, F; Frank, JA; Kappos, L; Miller, DH; Simon, JH; Wolinsky, JS; Filippi, M; Sylvia Lawry Centre for MS Research
MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability.
NEUROLOGY. 2006; 66: 1384-1389.
Doi: 10.1212/01.wnl.0000210506.00078.5c
Web of Science
PubMed
FullText
FullText_MUG
2002
Baumhackl, U; Eibl, G; Ganzinger, U; Hartung, HP; Mamoli, B; Pfeiffer, KP; Fazekas, F; Vass, K; Austrian MS Study Committee
Prevalence of multiple sclerosis in Austria. Results of a nationwide survey.
NEUROEPIDEMIOLOGY. 2002; 21(5): 226-234.
Doi: 10.1159/000065640
Web of Science
PubMed
FullText
FullText_MUG
1998
Ebers, GC; Rice, G; Lesaux, J; Paty, D; Oger, J; Li DKB, Beall S, Devonshire V, Hashimoto S, Hooge J, Kastrukoff L, Krieger C, Mezei M, Seland P, Vorobeychi G, Morrison W, Nelson J, Freedman MS, Chrisie S, Nelson R, Rabinovitch H, Freedman C, Hartung HP, Rieckmann P, Archelos J, Jung S, Weilbach F, Flachenecke P, Sauer J, Hommes O, Jongen P, Brouwer S, McLeod J, Pollard J, Ng R, Sandberg-Wollheim M, Kallen K, Nilsson P, Ekberg R, Lundgren A, Jadback G, Wikstrom J, Multanen J, Valjakka M, Carton H, Lissoir F, Declerq I, Vieren M, Peeters E, Dubois B, Dekeersmaeker E, Van Herle A, Hughes RAC, Sharrack B, Soudain S, Panelius M, Eralinna J, Soilu-Hanninen M, Murto S, Medaer R, Broeckx J, Vanroose E, Bogaers A, Blumhardt LD, Edwards S, Liu C, Orpe V, Barnes D, Schwartz M, Stoy N, Harraghy C, Bertelsmann F, Uitdehaag B, Nasseri K, Chofflon M, Roth S, Kappos L, Huber S, Bellaiche Y, Senn C, King J, Jubert J, Whitten S, Newsom-Davis JM, Palace J, Lee M, Evangelou N, Pinto A, Cavey A, Sindic CJM, Monteyne P, Verougstraete D, Van Doorn PA, Moll W, Visser L, Willems M, Martina I, Buljevac D, Loman L, Bates D, Pandit D, Irving J, Rhodes B, Riddehough A, Zhao GJ, Wang X, Cheng Y, Ammoury N, Dupont F, Galazka A, Hyde R, Olson M, Pernin MO, Abdul-Ahad AK, Hommes O, Noseworthy J, Borden E, O'Brien P, Wolinsky J
Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
LANCET. 1998; 352(9139): 1498-1504.
Doi: 10.1016/S0140-6736(98)03334-0
Web of Science
PubMed
FullText
FullText_MUG
Kappos, L; Polman, C; Pozzilli, C; Thompson, A; Dahlke, F; Knight R, Hern J, Coleman R, Gerrie L, Cooper G, Moore J, Boringa J, van Oosten B, Ronner H, Schrijver H, Truyen L, Montalban J, Rio J, Tintore M, Jacas C, Marzo E, Lechner-Scott J, Huber S, Lienert C, Brunnschweiler H, Hawkins S, Droogan A, McDonnell G, Duddy M, McKinstry S, Altenkirch H, Baum K, Einhaupl K, Marx P, Poewe W, Walter G, Akman H, Brockmeier B, Scherer P, Zschenderlein R, Schmierer K, Gelderblom H, Hartmann A, Stapf C, Luschow A, Mackert B, Schumacher H, Masuhr F, Hempel T, Zimmermann R, Munch M, Francis D, Heafield M, Al-Memar A, Winer J, Chong M, Brochet B, Gayou A, Auriacombe S, Dousset V, Wiles C, Thomas F, Pickersgill T, Hinds N, Dawson K, Hughes T, Hutchinson M, Murphy R, Redmond J, Webb S, Stoll G, Jander S, Hagemann G, Koller H, Hanemann C, Kolmel H, Reichel D, Petereit K, Thieme A, Khatami A, Neumann M, Amaducci L, Massacesi L, Siracusa G, Amato M, Bartolozzi L, Repice A, Minderhoud J, De Keyser J, Zorgdrager A, Zwanikken C, Poser S, Polak T, Gunther A, Bitsch A, Borner T, Weber F, Wikstrom J, Farkkila M, Majuri H, Sumelahti M, Telakivi T, Fredrikson S, Martin C, Miller D, O'Riordan J, Brex P, Kapoor R, Werring D, Confavreux C, Brunet P, Hannoun D, Brudon F, Moreau T, Blanc S, D'Hooghe M, Jacobs K, Lissoir F, Demonty L, Comi G, Colombo B, Rossi P, Rodegher M, Santuccio G, Martinelli F, Hohlfeld R, Walther E, Goebels N, Dang T, Lindert R, Voltz R, Cartlidge N, Bates D, Moran G, Pandit L, Westwood M, Haller P, Sommer J, Bitter J, Suss F, Mellies J, Mucha P, Lyon-Caen O, Degos JD, Roullet E, Lubetzki C, Creange A, Tourbah A, Pez D, Lecanuet P, Nicolt P, Edan G, Belliard S, De Marco O, Cahagne V, De Burghgraeve V, Brunet I, Fieschi C, Millefiorini E, Gasperini C, Buttinelli C, Frontini M, Howell S, Hadjivassiliou M, Gibson A, Graham A, Harkness K, Lawden M, Clanet M, Wauban E, Azais-Vuillemin C, Lau GKK, Louis C, Panelius M, Ruutiainen J, Eralinna J, Soilu-Hanninen M, Gold R, Hartung HP, Jung S, Bayas A, Flachenecker P, Weilbach F, Archelos J, Kollegger H, Vass K, Asenbaum S, Chatsakos T, Beckmann K, Ghazi M, Wagner K, Miltenburger C, McFarland H, Petkau J, Sabouraud O, Toyka K
Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS.
LANCET. 1998; 352(9139): 1491-1497.
Doi: 10.1016/S0140-6736(98)10039-9
Web of Science
PubMed
FullText
FullText_MUG